Importance: While the prevalence of ductal carcinoma in situ (DCIS) of the breast has increased substantially following the introduction of breast-screening methods, the clinical significance of early detection and treatment for DCIS remains unclear.\ud \ud Objective: T... View more
1.Dodwell D, Clements K, Lawrence G et al on behalf of the Sloane Project Steering Group. Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilization in the UK. Interim findings from the Sloane Project. BJC; 2007; 97: 725-729 2. Sagara Y, Mallory MA, Wong S, et al. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A PopulationBased Cohort Study. JAMA Surg. 2015;150(8):739-745 3. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. Independent UK Panel on Breast Cancer Screening.
The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380 (9855):1778-1786.
4. Jørgensen KJ and Gøtzsche P.C. Who evaluates public health programmes? A review of the NHS Breast Screening Programme.
J R Soc Med. 2010; 103 (1):14-20 5. Siobhan O'Connor Why Doctors Are Rethinking Breast-Cancer Treatment Oct. 12, Time Magazine 2015 6. Fallowfield L, Francis A, Catt S, Mackenzie M, Jenkins V. Time for a low-risk DCIS trial: harnessing public and patient involvement.